Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
09/23/2003 | US6623938 Human I-FLICE (Inhibitor of FLICE (FADD-like ICE)) polynucleotides; vectors, host cells and recombinant methods for producing the same |
09/23/2003 | US6623929 Reacting polymerase with a substrate; modulating the conformation of the polymerase by applying monochromatic light to allow incorporation of the nucleotide; bacteriorhodopsin |
09/23/2003 | US6623735 Vaccine containing a thiol protease |
09/23/2003 | CA2113477C Yeast strains with stable integration of heterologous genes |
09/23/2003 | CA2098122C Anti-atherosclerotic aryl compounds |
09/21/2003 | CA2421146A1 Ethanolaminephosphate cytidylyltransferase gene and promoter |
09/19/2003 | CA2422583A1 Marburg i mutant of factor vii-activating protease (fsap) as risk factor for arterial thrombosis |
09/18/2003 | WO2003076637A1 Process for the preparation of l-amino acids using strains of the family enterobacteriaceae |
09/18/2003 | WO2003076635A1 Process for the preparation of l-amino acids using strains of the family enterobacteriaceae |
09/18/2003 | WO2003076633A2 Inhibition of germination in plants |
09/18/2003 | WO2003076630A1 Method of controlling ethanol production and mass production of lactic acid and transformant therefor |
09/18/2003 | WO2003076629A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
09/18/2003 | WO2003076628A1 Scytalone dehydrogenase gene showing tolerance to agricultural pesticide |
09/18/2003 | WO2003076626A1 Gene participating in the synthesis of brassinosteroid |
09/18/2003 | WO2003076624A1 Novel n-acetylglucosamine transferase, nucleic acid encoding the same and use thereof in diagnosing cancer and/or tumor |
09/18/2003 | WO2003076623A1 Cdc7-ASK KINASE COMPLEX, SUBSTRATE OF THE KINASE COMPLEX, ANTIBODY SPECIFIC TO THE SUBSTRATE, AND METHOD OF SCREENING COMPOUND CAPABLE OF INHIBITING Cdc7-ASK KINASE USING THE SAME |
09/18/2003 | WO2003076618A1 Reversible toxin and the use thereof |
09/18/2003 | WO2003076616A1 Dna encoding lactate dehydrogenase and utilization thereof |
09/18/2003 | WO2003076611A1 Alleles of the acea gene from coryneform bacteria |
09/18/2003 | WO2003076610A2 Variants of human kallikrein-2 and kallikrein-3 and uses thereof |
09/18/2003 | WO2003076609A1 Rhomboid-related protein |
09/18/2003 | WO2003076582A2 A novel protein kinase induced during sporangial cleavage in the oomycete phytophthora infestans |
09/18/2003 | WO2003076580A2 High throughput mutagenesis screening method |
09/18/2003 | WO2003076577A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
09/18/2003 | WO2003076576A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
09/18/2003 | WO2003076572A2 Novel nucleic acid molecules and polypeptides encoding baboon tafi |
09/18/2003 | WO2003076565A2 Methods of using 46828, a human acyl-coa synthetase |
09/18/2003 | WO2003076561A2 Recombinase fusion protein with enhanced cellular uptake |
09/18/2003 | WO2003076462A1 Use of recombinant trypsin for vaccine production |
09/18/2003 | WO2003076461A2 Dimeric tf antagonist comprising two factor vii polypeptides |
09/18/2003 | WO2003076333A2 Crystalline structure of human mapkap kinase-2 |
09/18/2003 | WO2003075925A1 Methods for reducing body fat and increasing a lean body mass by reducing stearoyl-coa desaturase 1 activity |
09/18/2003 | WO2003075847A2 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS |
09/18/2003 | WO2003075845A2 Immunogenicity of glucan binding protein |
09/18/2003 | WO2003075844A2 Compositions and methods for preventing and treating cancer via modulating ube1l, isg15 and/or ubp43 |
09/18/2003 | WO2003075834A2 Activated protein c formulations |
09/18/2003 | WO2003062468A3 Method for binding site identification using a multi-scale approach |
09/18/2003 | WO2003061570A3 Engineered binding proteins |
09/18/2003 | WO2003059252A3 Use of a novel cell surface protease from group b streptococcus |
09/18/2003 | WO2003054159A3 Modulating insulin receptor signaling through targeting facl |
09/18/2003 | WO2003038082A3 Novel alkaline protease variants and detergents and cleansers containing these novel alkaline protease variants |
09/18/2003 | WO2003037363A3 Non-neurotoxic plasminogen activating factors for treating stroke |
09/18/2003 | WO2003035861A3 Thrombin-cleavable chimeric proteins |
09/18/2003 | WO2003025191A3 Pseudotyped retroviral vector system |
09/18/2003 | WO2003014358A3 Detergent and cleaning agent with hybrid alpha amylases |
09/18/2003 | WO2003006644A3 Lipase/acyltransferase |
09/18/2003 | WO2003004675A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
09/18/2003 | WO2003004671A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
09/18/2003 | WO2003004628A3 Method for purifying an enzyme, a purified enzyme produced thereby, and use of this enzyme |
09/18/2003 | WO2002103022A3 Transgenic cells expressing clucosyltransferases which glucosylate parabenzoic acid |
09/18/2003 | WO2002097079A3 Gene encoding molecular motor protein and diagnosis method for the disease related to the gene |
09/18/2003 | WO2002079430A3 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
09/18/2003 | WO2002077267A3 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon |
09/18/2003 | WO2002057458A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
09/18/2003 | WO2002050287A3 Multifunctional protease inhibitors and their use in treatment of disease |
09/18/2003 | WO2002048328A9 Isolated human kinase proteins, their encoding nucleic acid molecules, and uses thereof |
09/18/2003 | US20030177537 Transgenic plant; genetic engineering |
09/18/2003 | US20030177535 Genes for altering mitochondrial function and for hybrid seed production |
09/18/2003 | US20030177534 Genetic engineered polypeptide; biosynthesis of cationic starch |
09/18/2003 | US20030177533 Variants of ADP-glucose pyrophosphorylase affecting phosphate sensitivity and other parameters |
09/18/2003 | US20030177532 Manipulation of starch granule size and number |
09/18/2003 | US20030177531 Regulating metabolism by modifying the level of trehalose-6-phosphate by inhibiting endogenous trehalase levels |
09/18/2003 | US20030177530 From cereals; transgenic plant; heat resistance; genetic engineering |
09/18/2003 | US20030177524 To uridine-5-monophosphate; nucleic acid coding decarboxylase |
09/18/2003 | US20030177523 Isolated nucleic acid; genetic engineering |
09/18/2003 | US20030177522 Genetic engineering; hybrids; transformated plants, seeds |
09/18/2003 | US20030177518 Plant gene |
09/18/2003 | US20030177516 Gut-specific gene expression in transgenic avians |
09/18/2003 | US20030177510 Testing drug, therapy for Alzheimer's disease using transgenic animal |
09/18/2003 | US20030177508 Elongase genes and uses thereof |
09/18/2003 | US20030177507 Transgenic animal model; determination variations in plaque deposits |
09/18/2003 | US20030176688 Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide |
09/18/2003 | US20030176680 High-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF) |
09/18/2003 | US20030176679 Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds |
09/18/2003 | US20030176678 Viricides, antitumor agents, antiproliferative agents, anticancer agents; genetic engineered Dna |
09/18/2003 | US20030176675 TyrA genes and uses thereof |
09/18/2003 | US20030176670 Multivalent macrolide antibiotics |
09/18/2003 | US20030176665 Soluble complexes of target proteins and peptidyl prolyl isomerase chaperones and methods of making and using them |
09/18/2003 | US20030176661 Novel antibody with specificity for colon cancer |
09/18/2003 | US20030176642 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors |
09/18/2003 | US20030176387 Regulation of human pyroglutamyl peptidase-like enzyme |
09/18/2003 | US20030176385 For modulating the expression of H-Ras, WNT-7B, acetylglucosaminyltransferase, voltage-gated K channel, IL-8, ion transport, Map3K8 and Thymidine kinase |
09/18/2003 | US20030176383 Antisense modulation of p38 mitogen activated protein kinase expression |
09/18/2003 | US20030176382 Treatment of hookworm infection |
09/18/2003 | US20030176375 Method of treating anemia |
09/18/2003 | US20030176351 Peptides and peptide analogues designed from a diabetes-associated autoantigen, and methods for their use in the treatment and prevention of diabetes |
09/18/2003 | US20030176338 Novel serine-threonine kinase |
09/18/2003 | US20030176331 Having therapeutic, diagnostic, and preventative benefits, particularly as immunotoxins; for therapy of cancer |
09/18/2003 | US20030176330 55562 and 21617, novel human proteins and methods of use thereof |
09/18/2003 | US20030176317 Stabilization of hypoxia inducible factor (HIF) alpha |
09/18/2003 | US20030176304 Protease variants and compositions |
09/18/2003 | US20030175970 Digestion using restriction enzyme; gel purification |
09/18/2003 | US20030175967 Animal cloning; vectors; genetic engineering |
09/18/2003 | US20030175949 Novel human kinase and polynucleotides encoding the same |
09/18/2003 | US20030175941 Regulation of human serine racemase enzyme |
09/18/2003 | US20030175940 Cell-wall degrading enzyme variants |
09/18/2003 | US20030175939 Diagnosis, therapy cancer; genetic engineering |
09/18/2003 | US20030175938 Antiinflammatory agents; autoimmune disease; anticancer agents; antitumor agents; wound healing agents |
09/18/2003 | US20030175937 Cathepsin O2 protease |
09/18/2003 | US20030175936 Poly - gamma - glutamic acid decomposing enzyme gene and method for producing poly - gamma - glutamic acid |